Ninety-day outcome rates of a prospective cohort of consecutive patients with mild ischemic stroke

Stroke

Volumn 43, Issue 2, 2012, Pages 560-562

  Khatri, Pooja ^a   Conaway, Mark R ^b   Johnston, Karen C ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

cerebral infarct; prognosis; stroke care

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; DIFFUSION WEIGHTED IMAGING; DISABILITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COHORT STUDIES; DEMOGRAPHY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISABILITY EVALUATION; FEMALE; GLASGOW OUTCOME SCALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; STROKE; TREATMENT OUTCOME;

EID: 84856454410     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.593897     Document Type: Article

References (9)

1. Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, et al. Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study. Stroke. 2009;40:2805-2811.
2. Barber PA, Zhang J, Demchuk AM, Hill MD, Buchan AM. Why are stroke patients excluded from tPA therapy? An analysis of patient eligibility. Neurology. 2001;56:1015-1020. (Pubitemid 32336306)
3. Kleindorfer D, Kissela B, Schneider A, Woo D, Khoury J, Miller R, et al. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: A population-based study. Stroke. 2004;35:e27-e29.
4. Khatri P, Kleindorfer DO, Yeatts SD, Saver J, Levine S, Lyden P, et al. Strokes with minor symptoms: An exploratory analysis of the NINDS rtPA trials. Stroke. 2010;41:2581-2586.
5. Smith EE, Abdullah AR, Petkovska I, Rosenthal E, Koroshetz WJ, Schwamm LH. Poor outcomes in patients who do not receive intravenous tissue plasminogen activator because of mild or improving ischemic stroke. Stroke. 2005;36:2497-2499. (Pubitemid 41566987)
6. Van den Berg JS, De Jong G. Why ischemic stroke patients do not receive thrombolytic treatment: results from a general hospital. Acta Neurol Scand. 2009;120:157-160.
7. Hills NK, Johnston SC. Why are eligible thrombolysis candidates left untreated? Am J Prev Med. 2006;31:S210-S216. (Pubitemid 44908854)
8. Fischer U, Baumgartner A, Arnold M, Nedeltchev K, Gralla J, Marco De Marchis G, et al. What is a minor stroke? Stroke. 2010;41:661-666.
9. Barrett KM, Ding YH, Wagner DP, Kallmes DF, Johnston KC, ASAP Investigators. Change in diffusion-weighted imaging infarct volume predicts neurologic outcome at 90 days: results of the Acute Stroke Accurate Prediction (ASAP) trial serial imaging substudy. Stroke. 2009; 40:2422-2427.